Papers matching “adjuvant endocrine therapy” 62
Not finding it? Sign in to also search OpenAlex live.
-
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial2023 EClinicalMedicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Vivianne C. G. Tjan‐Heijnen, Senna W. M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
16citations -
Side-effects in women treated with adjuvant endocrine therapy for breast cancer2025 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Roxanne Gal, Anne Maria May, Marilot C. T. Batenburg, Femke van der Leij, Rhodé M. Bijlsma, Helena Marieke Verkooijen, +5 more
12citations -
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial
Sonja B. Vliek, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, Annelot G.J. van Rossum, Vincent Olaf Dezentjé, Agnes Jager, +12 more
21citations -
133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
V.C.G. Tjan-Heijnen, S.W.M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
5citations -
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer2021 Journal of Geriatric Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Annelieke A. Lemij, Nienke A. de Glas, Marloes G.M. Derks, Esther Bastiaannet, Jos W.S. Merkus, Titia E. Lans, +8 more
3citations -
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy2024 JAMA Network Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Laura van ‘t Veer, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, Cornelis J. H. van de Velde, Miranda Kleijn, Christa Dreezen, +3 more
12citations -
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer2023 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, Marco Angelo Colleoni, +32 more
229citations -
Neoadjuvant endocrine therapy often leads to breast and axilla‐conserving surgery in stages II and III hormone receptor‐positive breast cancer patients: A registry study2025 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Layla Andour, Judith R. Kroep, Hein Putter, Rob A.�E.�M. Tollenaar, Wilma E. Mesker, Marieke Evelien Straver
4citations -
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, Elma Meershoek‐Klein Kranenbarg, +4 more
133citations -
Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial2026 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, Marco Angelo Colleoni, +33 more
8citations -
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors2022 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Annemiek van Ommen‐Nijhof, Judy N. Jacobse, Lars C. Steggink, Joop D. Lefrandt, Jourik A. Gietema, Flora E. van Leeuwen, +2 more
4citations -
Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial2026 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Tejal Deepak Durgekar, Shyamili Goutham, Xi Zhang, Elma Meershoek‐Klein Kranenbarg, Badada Ananthamurthy Savitha, Shrivastava Pn, +8 more
1citations -
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer2020 Therapeutic Advances in Medical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ulrike Anneliese Nitz, Oleg Gluz, Hans Heinrich Kreipe, Matthias Christgen, Sherko Küemmel, Frederick L. Baehner, +16 more
46citations -
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer2022 Annals of Oncology article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent
Charles E. Geyer, Judy Ellen Garber, Richard D. Gelber, Greg Yothers, L. Ross, Priya Rastogi, +90 more
473citations -
The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration2021 Cancer Reports article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sirus Djahansouzi, Bettina Hanstein, Daniel Rein, Michel Clees, Werner H. Rath
8citations -
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare2023 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Volkmar Müller, Peter Andreas Fasching, Naiba Nabieva, Tanja Natascha Fehm, Marc Thill, Marcus Schmidt, +13 more
1citations -
A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients2024 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Anabel Sanchez‐Spitman, Stefan Böhringer, Vincent Olaf Dezentjé, Hans A. J. Gelderblom, Jesse Joachim Swen, Henk‐Jan Guchelaar
11citations -
Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Josephine Lopes Cardozo, Danalyn Byng, Caroline A. Drukker, Marjanka K. Schmidt, Mary Ann E. Binuya, Laura van ‘t Veer, +5 more
16citations -
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial2023 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Marcus Schmidt, Ulrike Anneliese Nitz, Toralf Reimer, Sabine Schmatloch, Heiko Graf, Marianne Just, +10 more
5citations